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INTRODUCTION
A major complication of total body irradiation (TBI)
used in preparing patients for bone marrow transplantation
(BMT) is pulmonary toxicity [1-12]. Despite the use of frac-
tionated irradiation, transmission blocks for attenuation of
dose, and reduced irradiation dose-rate, pulmonary toxicity
remains a major clinical problem in TBI [8,11-14]. Radia-
tion pulmonary damage is associated with an initial acute
reaction of pneumonitis, in which bronchoalveolar and
endothelial cellular swelling is associated with significant
alveolar transudates and accumulation of inﬂammatory cells
[8-9,15-24]. Acute reactions are often treated with nons-
teroidal antiinﬂammatory agents, but may require adminis-
tration of corticosteroids, the withdrawal of which can be
problematic because of the recurrence of pathophysiological
sequelae [10-12,25]. A subpopulation of patients recovering
from acute radiation pneumonitis, as well as another sub-
group not developing the acute reaction, will develop a late
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ABSTRACT
Pulmonary toxicity is a major complication of total body irradiation used in preparation of patients for bone marrow
transplantation. The mechanism of the late pulmonary damage manifested by fibrosis is unknown. In
C57BL/6NHsd mice, manganese superoxide dismutase–plasmid/liposome (MnSOD-PL) intratracheal injection
24 hours prior to 20 Gy single-fraction irradiation to both lungs significantly reduced late irradiation damage. Single
intratracheal injections of MnSOD-PL, at concentrations as low as 250 µg of plasmid DNA, in a constant volume of
78 µL of liposomes, reduced late damage. To determine whether a slowly proliferating population of cells in the
lung was responsible for initiation of fibrosis and was altered by MnSOD-PL therapy, 20 Gy total lung–irradiated
mice were examined at serial time points for bromodeoxyuridine (BrdU) uptake in sites of cell division. There was
low-level, but nonsignificant, increased cell proliferation detected at 80 days, with a significant increase at 100 days,
120 days, and at the time of death. Immunohistochemical assay for up-regulation of adhesion molecules associated
with recruitment, transendothelial migration, and proliferation of bronchoalveolar macrophages revealed significant
up-regulation of vascular cell adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1) at
100 days with further increases up to the time of death. Increases were first detected in endothelin-positive
endothelial cells. MnSOD-PL administration prior to irradiation decreased both BrdU incorporation and delayed
expression of VCAM-1 and ICAM-1. The data indicate that the appearance of late irradiation-induced pulmonary
fibrosis is associated with the up-regulation of adhesion molecules and suggest that potential targets for interven-
tion may focus on the pulmonary vascular endothelium.
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picture of irradiation ﬁbrosis [8]. Fibrosis has been associ-
ated with the detection of increased levels of collagen depo-
sition and elaboration of transforming growth factor β1
(TGFβ1) and TGFβ2 and other cytokines [26-36]. The
molecular mechanism(s) and cellular events associated with
initiation of the late irradiation-induced pulmonary lesion
are not known.
In C57BL/6NHsd mice receiving 20 Gy single-fraction
total lung irradiation, the pathophysiological events associ-
ated with acute and chronic pulmonary irradiation damage
are similar to those in the human [37-43]. In particular, late
irradiation fibrosis, termed organizing alveolitis in the
mouse model, is characterized by the proliferation of ﬁbro-
blasts in the periphery of the lung at approximately 100 days
after irradiation [43]. These lesions progress over the next
20 to 50 days and are associated with signiﬁcant respiratory
compromise and death [42-43].
We have previously demonstrated that intratracheal (IT)
injection of manganese superoxide dismutase–plasmid/lipo-
some (MnSOD-PL) prior to irradiation signiﬁcantly reduces
the extent and severity of organizing alveolitis in
C57BL/6NHsd mice and improves survival [37-41]. Previous
studies demonstrated that MnSOD-PL administration prior
to irradiation reduced the second peak of elevation in levels of
TGFβ1-β2 messenger RNA detected in lung specimens
removed at days 100 and 120 after irradiation up to the time
of death [38]. The cellular and molecular mechanisms of the
late elevation in levels of TGFβ1-β2 are not known. One
hypothesis to explain the late elevation in transcription of
TGFβ1-β2 and the initiation of organizing alveolitis/ﬁbrosis
is that a slowly proliferating population of cells in the lung
with a latent period of 100 days initiates the process of late
irradiation damage [8]. A second hypothesis is that inﬂamma-
tory cells, including bronchoalveolar macrophages (BAMs),
are recruited to sites of irradiation injury by up-regulation of
speciﬁc adhesion molecules that reach a critical threshold for
signaling subsequent events [34-36,44-48].
In the present studies, after administering 20 Gy irradia-
tion, we used the bromodeoxyuridine (BrdU) labeling
technique to examine the lungs of C57BL/6NHsd mice at
multiple time points for the detection of a slowly proliferat-
ing cell population in the endothelial or bronchoalveolar
compartment. We also tested whether adhesion molecules
known to be associated with inflammatory cell migration
and proliferation might be up-regulated at the 100-day late
time point. Initiation of late irradiation damage was
decreased by IT injection of MnSOD-PL (in constant vol-
umes of 78 µL) in plasmid DNA concentrations as low as
250 µg prior to delivery of 20 Gy single-fraction irradiation.
The results demonstrate that MnSOD-PL administration
modiﬁes the increase in BrdU uptake by both macrophages
and ﬁbroblasts and increases VCAM-1 and ICAM-1 expres-
sion in endothelin-positive endothelial cells that are
detected in areas of developing organizing alveolitis/ﬁbrosis
at approximately day 100 after pulmonary irradiation.
MATERIALS AND METHODS
Mice, Irradiation, and Histopathology
In the present studies, C57BL/6NHsd mice (Harlan
Sprague Dawley, Indianapolis, IN) were used, whereas in
prior studies, we have used C57BL/6J mice (both strains
were obtained from Jackson Laboratories, Bar Harbor, ME).
C57BL/6NHsd female mice (body wt, 25-30 g) were
injected IT or intravenously (IV) with MnSOD-PL or bac-
terial β-galactosidase gene–plasmid/liposome (LacZ-PL) at
0 to 500 µg of plasmid DNA and received 20 Gy irradiation
24 hours later to both lungs using a Varian 600C Linear
Accelerator (Varian Medical Systems, Palo Alto, CA). The
mice were shielded so that only the pulmonary cavity was
irradiated. The mice were watched on a daily basis for
development of pulmonary fibrosis. Other mice received
liposomes, but not plasmid. The mice were sacrificed at
varying time points, lungs were excised, and 5 sections (each
10 microns thick) of each of 5 lobes were prepared using a
Shandon AS620E Cryotome (Shandon/Lipshaw, Pittsburgh,
PA). The sections were hematoxylin-eosin stained according
to published methods [41].
Construction and Use of a Hemagglutinin
Epitope–Tagged MnSOD
A hemagglutinin (HA) epitope–tagged MnSOD trans-
gene was constructed that maintained biochemical activity.
The HA tag was present in the pCGN vector prior to cloning
in the MnSOD gene. The HA tag was located downstream of
the cytomegalovirus (CMV) promoter and is upstream of the
multiple cloning site. The MnSOD sequence was inserted
into that vector using a 5′ XbaI site and a 3′ KpnI site located
in the multiple cloning site and present on the MnSOD gene
as part of the polymerase chain reaction primers. The protein
product, therefore, contained an N-terminal HA tag, fol-
lowed by the mitochondrial localization sequence (intrinsic to
the coding sequence), followed by the mature protein at the
C-terminal end. C57BL/6NHsd female and other mice (body
wt, 25-30 g) were injected IT or IV with HA-epitope–tagged
MnSOD-PL consisting of 500 µg of HA-MnSOD-PL in
50 µL of plasmid DNA complexed with 28 µL of lipofectant.
The mice were anesthetized with Nembutal, the trachea was
surgically exposed, and a 28-gauge needle was used to inject
HA-MnSOD-PL into the trachea. IV injection of HA-
MnSOD-PL was performed via the tail vein. The mice were
sacriﬁced 24 hours later. The lungs were expanded in Opti-
mum Temperature Cutting (OCT) compound (Sakura Fine
Tek, Torrance, CA), excised, frozen in OCT, and sectioned.
The sections were examined for expression of the HA-
MnSOD-PL transgene, as described below, using an anti-
body against the HA epitope. Fluoroscein isothiocyanate
(FITC)-monoclonal anti-HA antibody was used to detect
HA-MnSOD-PL in the experimental lung sections. Epitope-
tagged HA-MnSOD-PL was prepared and IT injected, as
was the pRK5-MnSOD preparation, according to published
methods [41]. The biochemical activity of HA-MnSOD-PL
was tested in vitro using a cell line prepared from adult
C57BL/6NHsd mouse lung cells according to published
methods [41,49]. The experiments were performed twice in
triplicate. The cells are referred to as tracheal-bronchial cells,
because they originated from either the trachea or bronchus.
BrdU Labeling of Lung Cell Division
Control mice and mice injected with MnSOD-PL
24 hours earlier were irradiated to 20 Gy. At times ranging from
0 to the time of death, mice were injected intraperitoneally
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with 50 mg/kg of BrdU. The mice were sacrificed 1 hour
later, and the lungs were then expanded with OCT, excised,
frozen in OCT, sectioned, and immunohistochemically
stained using a BrdU IHC System staining kit (Oncogene
Research Products, Boston, MA). The sections were ﬁxed by
incubation in methanol for 30 minutes at 4°C, followed by
incubation in 3% hydrogen peroxide (H2O2) in methanol
and incubation of the sections in denaturing solution at room
temperature for 30 minutes. Nonspecific binding was
blocked by incubating the sections in 3% goat serum. The
sections were then incubated with a biotinylated mouse anti-
BrdU antibody (Oncogene Research Products) for 30 minutes
and washed with phosphate buffered saline (PBS). Peroxidase-
conjugated streptavidin was added, and the sections were
incubated for 10 minutes, then washed with PBS. A
diaminobenzedine mixture (Oncogene Research Products)
was added to the sections, which were then incubated in
the dark for 2 to 3 minutes, washed, and stained with hema-
toxylin, covered with Histomount (Oncogene Research
Products), coverslipped, and examined microscopically.
Quantitative Immunohistochemical Detection of
VCAM-1, ICAM-1, Platelet-Selectin, and 
Erythrocyte-Selectin
Control mice and mice injected with MnSOD-PL were
sacriﬁced at time points ranging from 0 to the time of death
after 20 Gy irradiation; the lungs were then expanded with
OCT, excised, frozen, and sectioned. The sections were
stained using murine antibodies against VCAM-1 (Pharmin-
gen 01811D; Pharmingen, San Diego, CA), erythrocyte (E)-
selectin (Pharmingen 09521D), platelet (P)-selectin
(Pharmingen 09481D), or ICAM-1 (Seikagaku America,
Falmouth, MA); the sections were ﬁxed in methanol, incu-
bated in 1% H2O2 for 2 minutes at room temperature, and
washed in PBS. Nonspeciﬁc binding was blocked by incu-
bating the sections in 2% goat serum for 3 minutes at room
temperature. The primary antibodies were diluted 1:50 and
placed on the tissue sections for 2 hours in a humidity box.
The slides were washed in PBS, and a biotinylated antirat
antibody was added to the sections. The sections were then
incubated for 30 minutes at room temperature, followed by
incubation with an avidin peroxidase macromolecular complex
for 1 hour and washing in PBS. An amino-ethylcarbazole
reagent (600 mg 3-amino-9-ethylcarbazole in 10 mL of
N,N-dimethylformamide mixed with 100 mL of 0.02 mol/L
sodium acetate, pH 5.2, plus 100 mL H2O2 solution)/
formamide solution was then placed on the sections, and
they were incubated for 10 minutes. The slides were washed
in PBS, stained with hematoxylin for 2 minutes, and washed
in water. The slides were mounted with antifade Histo-
mount and coverslipped.
To both demonstrate and quantitate endothelial cell
expression of ICAM-1 and VCAM-1 following irradiation to
the lung, lung sections were costained with FITC-conjugated
antibody to either ICAM-1 (hamster) or VCAM-1 (murine)
and a rabbit antibody to endothelin (endothelin [Ab-2] poly-
clonal [catalog no. PC266, lot no. D14892], Oncogene
Research Products) complexed with a phycoerythrin (PE)-
conjugated goat antirabbit immunoglobulin G antibody
(Oncogene Research Products). To determine the best con-
centration of antiendothelin antibody to be used in staining,
lung sections from nonirradiated and irradiated mice were
stained with 1:50, 1:100, or 1:250 dilutions of antiendothelin
antibody. The sections were then stained with a 1:100 dilu-
tion of PE-conjugated goat antirabbit antibody (to determine
the endothelin-positive cells) and examined using a Nikon
FXA epiﬂuorescence differential-interference contrast (DIC)
light microscope (Nikon, Melville, NY).
We scored positive cells in each of 10 sections, counting
more than 1000 cells per section. To determine the optimal
concentration of (hamster) anti–ICAM-1 or (murine) anti–
VCAM-1, lung sections from nonirradiated mice or mice that
received 20 Gy irradiation 120 days previously were stained
with a 1:50, 1:100, or 1:250 dilution of FITC-conjugated
anti–ICAM-1 or FITC-conjugated anti–VCAM-1. The
slides were examined using a fluorescent microscope, and
the percentage of 1000 cells expressing ICAM-1 or VCAM-1
in each of 10 sections were scored. The antibody concentra-
tion that gave the most consistent result with the least auto-
ﬂuorescence was selected, and then lung sections from mice
given 0 or 20 Gy irradiation were fixed in methanol. We
blocked nonspeciﬁc binding by incubating the cells in 2%
goat serum, washing in PBS, incubating slides with a 1:100
dilution of either FITC-conjugated anti–ICAM-1 or FITC-
conjugated anti–VCAM-1 and a 1:100 dilution of antien-
dothelin antibody for 2 hours at room temperature. The
slides were mounted with antifade Histomount, cover-
slipped, and examined using a Nikon FXA epifluorescence
DIC light microscope. PE-labeled (red) cells indicated
endothelin positivity and the FITC-labeled (green) cells
indicated ICAM-1 and VCAM-1 positivity. Percentages of
endothelin-positive cells and the subset of ICAM-1– and
VCAM-1–positive cells were calculated using a dual-filter
cube to look at the green ﬂuorescence (530 nm) and the red
ﬂuorescence (615 nm); at the same time, the percentage of
cells that were both endothelin positive and VCAM-1 or
ICAM-1 positive (yellow) was scored.
Pulmonary Endothelial Cell Culture
C57BL/6NHsd mice were sacrificed and the thoracic
cavity was exposed. Lungs were perfused by injecting 5 mL
of PBS through the left ventricle, removed, rinsed, minced,
and incubated for 45 minutes at 37°C in serum-free Dulbec-
co’s Modiﬁed Eagle’s Medium (DMEM) containing 100 Units
of collagenase per mL. Cells were passed through an 18-gauge
needle and filtered through a 70-µm filter; 5 mL of cold
DMEM was added to the cells, and the mixture was cen-
trifuged for 5 minutes at 100 rpm. The supernatant was
removed and the cells were resuspended in media containing
an antiplatelet endothelial cell adhesion molecule (PECAM)
monoclonal antibody attached to Dynabeads (Dynal Biotech,
Oslo, Norway), incubated for 30 minutes at 4°C with gentle
mixing, then incubated in a Dyna MPC Unit (Dynal
Biotech) for 2 minutes. The supernatant was removed, the
beads were washed 5 times in PBS, and the endothelial cells
were digested from the beads by incubating the beads in
1 mL of trypsin/ethylenediaminetetracetic acid (EDTA) for
5 minutes at 37°C. The cells were washed, resuspended, and
grown in DMEM containing 5 µg/mL insulin, 30 µg/mL
endothelial cell growth supplement, 15% fetal bovine serum,
20 mmol/L N-[2-hydroxyethyl]piperazine-N-[2-ethanesul-
fonic acid] (HEPES), and 10 Units/mL heparin.
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The endothelial cells were transferred to 4-chambered
microscope slides and transfected with the HA-MnSOD
plasmid using lipofectant by mixing 10 µg of plasmid DNA
with 20 µg of lipofectant in a total volume of 200 µL of
serum-free RPMI 1640 medium and incubating for 30 min-
utes at 37°C. The endothelial cells were washed twice with
PBS. The DNA/liposome complex was diluted to 1 mL of
serum-free RPMI 1640 medium, and 200 µL was added to
each chamber. The cells were incubated at 37°C for 5 hours,
at which time the cells were washed with PBS and 400 µL of
RPMI 1640 medium containing 10% fetal calf serum. In
other chambers, cells were treated in the same manner,
except the liposomes contained no plasmid DNA. The
chambers were irradiated to 20 Gy 24 hours later and
stained for expression of VCAM-1, ICAM-1, P-selectin, or
E-selectin, as described above, 24 hours after irradiation.
Statistics
Analysis of survival data comparing control irradiated
mice and LacZ-PL–injected mice with the different
MnSOD-PL groups was performed using a function called
Survdiff using inverse Wilcoxon paired comparisons [50-51].
A Student t test [52,53] as part of GraphPad’s Prism Statisti-
cal Analysis Program (GraphPad Software, San Diego, CA)
was used to analyze the data comparing different irradiation
groups with control or MnSOD-PL–injected mice.
Animal Welfare
The Institutional Animal Care and Use Committee of
the University of Pittsburgh approved all protocols. The
Central Animal Facility of the University of Pittsburgh pro-
vided veterinary care in strict accordance with the Institu-
tional Animal Care and Use Committee of the University of
Pittsburgh guidelines. The mice were housed in specific
pathogen-free conditions in the presence of sentinel mice
that were monitored once a month for pathogens. All sen-
tinel mice were negative for all pathogens tested, in particu-
lar for those that cause pneumonitis.
RESULTS
Dose Levels of MnSOD Plasmid DNA in
Plasmid/Liposomes Required to Increase Survival 
of C57BL/6NHsd Mice Irradiated to 20 Gy
To determine the dose of MnSOD plasmid DNA in a
constant volume of 78 µL of plasmid/liposomes required to
prevent late irradiation pulmonary damage, groups of
C57BL/6NHsd female mice (body wt, 25-30 g) were
injected IT 1 day prior to irradiation with doses of 500, 250,
100, or 50 µg of MnSOD plasmid DNA. The mice each
received 20 Gy irradiation to both lungs and were followed
for morbidity and signiﬁcant pulmonary damage as detected
by loss of weight and difficulty in breathing. Control ani-
mals receiving 250, 50, or 0 µg of LacZ plasmid DNA
prior to irradiation had mean survival times of 138.8 ± 4.2,
140.9 ± 2.9, and 137.6 ± 5.4 days after irradiation, respec-
tively (Table). In contrast, mice that received MnSOD-PL
at plasmid DNA concentrations of 50 µg (survival, 152.4 ±
6.4 days) or 100 µg (survival, 144.6 ± 1.9 days) showed
improvement in survival times, with statistically signiﬁcant
improvement occurring in groups receiving 250 µg or
500 µg (Table). These results conﬁrm and extend our prior
results of MnSOD-PL administration prior to radiation and
show a protective effect at a 2-fold lower plasmid DNA dose
compared to that reported in previous publications [37-
41,54]. The results also establish the similarity of the patho-
logic sequelae of pulmonary irradiation between C57BL/6J
and C57BL/6NHsd mice.
Identification of Cellular Sites of Uptake of 
MnSOD-PL Using an HA Epitope–Tagged Construct
Considering the detectable effect of relatively low doses
(50 µg) of MnSOD DNA providing protection to the lung
from irradiation, we performed studies to determine which
cells were transfected by IT injection of MnSOD-PL and
how delivery of IT injections compared to that of IV injec-
tions of MnSOD-PL. It was reasoned that endothelial cells
might be less effectively transfected by the IT compared to
the IV route, perhaps allowing us to target further studies to
a speciﬁc cell population. To facilitate targeting and analysis
of MnSOD-PL delivery to speciﬁc cells within the airway and
bronchoalveolar lavage cells, we have used an HA-epitope–
tagged construct, HA-MnSOD (Figure 1).
The biological effectiveness of the epitope-tagged HA-
MnSOD-PL construct was demonstrated in an in vitro colori-
metric assay measuring the reduction of nitro blue tetrazolium
(NBT) by superoxides. C57BL/6NHsd mouse tracheal-
bronchial cells transfected with HA-MnSOD-PL demonstrated
a significant increase (P = .0015) in MnSOD biochemical
activity of 6.7 ± 0.29 units of MnSOD activity per 1 mg of
protein compared with 3.9 ± 0.41 units of MnSOD activity
per 1 mg of protein for control tracheal-bronchial cells, as
detected using our assay specific for MnSOD biochemical
activity in 2 experiments performed in triplicate.
In previous studies, it was difﬁcult to determine which
cells were transfected following IT injection of MnSOD-PL.
Using HA-MnSOD-PL, we determined which cells
Effect of Varying Doses of MnSOD-PL prior to 20 Gy Irradiation on the
Mean Survival Time of C57BL/6NHsd Mice*
Treatment Groups Mean No. of Days P
20 Gy irradiation 137.6 ± 5.4
20 Gy + LacZ-PL (250 µg) 138.8 ± 4.2
20 Gy + LacZ-PL (50 µg) 140.9 ± 2.9
20 Gy + MnSOD-PL (500 µg) 154.9 ± 4.7† .015
20 Gy + MnSOD-PL (250 µg) 165.7 ± 6.0† .009
20 Gy + MnSOD-PL (100 µg) 144.6 ± 1.9
20 Gy + MnSOD-PL (50 µg) 152.4 ± 6.4
*C57BL/6NHsd mice were intratracheally injected with doses of
MnSOD-PL or LacZ-PL (50-500 µg of DNA). Twenty-four hours
later, control mice as well as mice injected with MnSOD-PL or LacZ-
PL were irradiated to a dose of 20 Gy to the pulmonary cavity. The
mice were followed for development of organizing alveolitis or ﬁbrosis,
as indicated by a loss of weight and difficulty in breathing, at which
time the mice were sacriﬁced. The mean survival time was calculated
and is shown with standard error of the mean. A Student t test was used
to compare the mean survival time for the different groups. 
†Only the mice injected with MnSOD-PL at 500-µg or 250-µg
doses demonstrated signiﬁcantly increased survival times compared to
the groups receiving 20 Gy only, 250 µg of LacZ-PL, or 50 µg of
LacZ-PL.
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expressed HA-MnSOD and whether IT or IV injections
provided similar delivery to endothelial compared to alveo-
lar type II bronchoalveolar cells (Figure 2). Mice were IV or
IT injected with 500 µg of HA-MnSOD plasmid DNA in
78 µL of plasmid/liposomes. Upon examination of lung
sections stained with an anti-HA antibody and an antien-
dothelin antibody, endothelial cells showed HA-MnSOD
expression (>50%) 24 hours following either route of injec-
tion (Figure 2). In contrast, the noninjected mice demon-
strated negative reactivity with the antibody to HA (Figure 2).
Thus, IV or IT injection of HA-MnSOD-PL resulted in
significant plasmid uptake in endothelial cells. There was
also detectable HA-MnSOD expression in bronchoalveolar
cells by the IT route of administration.
Detection of Significant Proliferation of
Bronchoalveolar Cells in the Periphery of the Lung 
at 100 Days after 20 Gy Single-Fraction Irradiation
To determine whether initiation of the late organizing
alveolitis (fibrosis) pulmonary lesion was associated with a
Figure 1. Hemagglutinin (HA) epitope–tagged MnSOD construct
(pCGN-HA-MnSOD).
Figure 2. Fluorochrome antibody (antihemagglutinin [HA]) detection of plasmid HA-MnSOD in the endothelial cells of C57BL/6J mouse lungs 24
hours after intratracheal or intravenous injection of plasmid/liposomes. Mice were injected either intratracheally or intravenously with HA-
MnSOD–plasmid/liposome and sacriﬁced 24 hours later; the lungs were then excised, frozen in OCT compound, and sectioned. The sections were
costained with an FITC-conjugated antibody to HA and a rabbit antiendothelin antibody, followed with PE-conjugated goat antirabbit antibody. The
sections were examined using a ﬂuorescent microscope. The top row panel is from a mouse injected intratracheally, whereas the middle row panel is
from a mouse injected intravenously. The bottom row panel is from a control noninjected mouse. The ﬁrst column shows ﬂuorescence from the PE-
labeled (red) endothelin-positive cells, whereas the middle column demonstrates the FITC-labeled (green) HA-positive cells. The third column dis-
plays the ﬂuorescence from both ﬂuorochromes, with the yellow color representing cells positive for both endothelin and HA. Intratracheal injections
resulted in HA expression in endothelial cells as well as in alveolar cells, whereas intravenous injections demonstrated HA expression in only the
endothelial cells (original magniﬁcation ×1000).
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slowly proliferating population of cells, mice were sacriﬁced
at days 0, 14, 80, 100, or 120 or at the time of premorbid
condition prior to death after receiving 20 Gy total lung
irradiation, and the lungs were examined for uptake of
BrdU. In other groups, mice injected with MnSOD-PL and
irradiated to 20 Gy were sacriﬁced at the same time as the
premorbid mice. The premorbid irradiated control group
demonstrated signs of pulmonary distress, such as difﬁculty
in breathing, lack of movement, and weight loss, whereas
the MnSOD-PL–treated mice were asymptomatic. The
explanted pulmonary sections were fixed (as described in
“Materials and Methods”) and assayed for immunohisto-
chemically detectable BrdU. As shown in Figure 3, there
was a low-level, but detectable, increase in cell proliferation
in control irradiated mice at day 80 (Figure 4B); however,
this level did not reach statistical signiﬁcance above that of
the pretreatment groups. In contrast, by day 100, there was
signiﬁcant increase in uptake of BrdU that was localized to
peripheral areas in the lung adjacent to the pleural walls
(Figure 4C), the area where organizing alveolitis and ﬁbrosis
develop. By day 120 or prior to death, there was a signiﬁcant
further increase in BrdU uptake in areas that were localized
immunohistochemically to the peripheral lung areas (adja-
cent to visceral pleura) associated with developing fibrosis
(Figure 4D). Irradiated mice injected with MnSOD-PL and
killed at the same time as the mice in Figure 4D had less
BrdU incorporation (Figures 3 and 4E). Examination of
endothelial cells by antiendothelin stain in these sections
failed to detect signiﬁcant BrdU uptake in endothelial cells
under conditions in which increased macrophage and ﬁbro-
blast BrdU uptake was observed.
Figure 3. Detection of increased BrdU uptake in irradiated
C57BL/6J mouse lungs. MnSOD-PL–injected or control C57BL/6J
mice were irradiated to 20 Gy to the pulmonary cavity. At days 0, 14,
80, 100, or 120, or immediately prior to death, the control mice were
injected with 50 mg/kg BrdU and sacriﬁced 1 hour later. MnSOD-PL
mice were injected with BrdU on the same day as the control mice and
were sacrificed 1 hour later. The lungs were expanded with OCT,
excised, frozen in OCT, and sectioned. The sections were stained for
BrdU uptake using an anti-BrdU antibody and examined microscopi-
cally for the percentage of cells showing BrdU uptake (scoring 1000 cells
in 5 sections from each of 5 lobes of at least 3 mice per point) (com-
pared to control nonirradiated lung at days 100 or 120 or immediately
prior to death [indicated by X], P < .05). Mice that were injected with
MnSOD-PL and then irradiated had a significantly lower level of
BrdU incorporation than did the control irradiated mice immediately
prior to death (indicated by #).
Figure 4. Demonstration of BrdU-positive mitotic cells within an area of pulmonary ﬁbrosis. Representative specimens from time points from Figure
3 at: day 0 (A), day 80 after 20 Gy irradiation (B), day 100 after 20 Gy irradiation (C), prior to death (D), or MnSOD-PL–treated mice at the time of
death of the control irradiated mice (E). Arrows show positive areas by anti-BrdU immunohistochemical staining at the periphery of the lung in areas
initiating near the visceral pleura. There was signiﬁcantly less BrdU incorporation in MnSOD-PL–treated irradiated lung (E) compared to that in con-
trol irradiated lung (D) immediately prior to death (A, C, and D, original magniﬁcation ×100; B and E, original magniﬁcation ×200).
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Correlation of BrdU-Uptake Sites to Microscopic
Sites of Increase in VCAM-1 and ICAM-1 at 80 Days
after 20 Gy Single-Fraction Lung Irradiation
We next investigated whether there was an immuno-
histochemically detectable increase in a specific adhesion
molecule in the lungs, specifically at the peripheral lung
areas that showed increased BrdU uptake, and whether this
increase occurred at time points prior to BrdU-detectable
increased cell proliferation. MnSOD-PL–injected mice
and control mice were irradiated to 20 Gy, sacrificed at
days 0, 14, 80, 100, or 120 or when moribund prior to
death, and examined immunohistochemically for detection
of E-selectin, P-selectin, ICAM-1, and VCAM-1. At 80
days after irradiation, there was a small increase detected
in VCAM-1 and ICAM-1 levels, but not in E-selectin or
P-selectin, in irradiated mice (Figure 5). The increases
were detected in the peripheral subpleural areas of lung
and also in other areas in a patchy nonuniform pattern.
Thus, the evidence suggested that the initiating events in
late fibrosis were associated with both adhesion molecule
up-regulation in endothelial cells at the time of detectable
fibroblasts and macrophage cell proliferation in areas of
developing organizing alveolitis/fibrosis.
As shown in Figure 5, there were signiﬁcant increases in
expression of ICAM-1 and VCAM-1 beginning at 100 days
after 20 Gy total lung irradiation in the control irradiated
mice compared to that in the MnSOD-PL–pretreated mice
or nonirradiated mice (P < .0001 and P < .0001, respec-
tively). The increases in ICAM-1 and VCAM-1 expression
in the control irradiated mice compared to the nonirradi-
ated mice persisted and increased further by day 120; these
increases were also signiﬁcantly greater immediately prior to
death (Figure 5). In mice injected with MnSOD-PL prior to
irradiation, increased expression of ICAM-1 and VCAM-1
was not detected until day 120 (Figure 5). There were no
detectable increases in levels of expression of E-selectin or
P-selectin in any of the mice.
The sites of increased expression of VCAM-1 and
ICAM-1 were critically examined in explanted lung samples.
There was a signiﬁcant increase in ICAM-1 in whole lung
cells at 100 days in the control irradiated mice, but not in
MnSOD-PL–pretreated mice. There was an increase in
expression of ICAM-1 and VCAM-1 in control irradiated
mice at 120 days (Figure 5). There was an increase in
VCAM-1 at day 100 in control irradiated mice compared to
that in MnSOD-PL–pretreated mice, and expression of
both ICAM-1 and VCAM-1 was further increased in con-
trol irradiated mice at day 120 (Figure 5). The ICAM-1 and
VCAM-1 elevations were next evaluated by immunoﬂuores-
cence staining to determine whether endothelial cells were
identiﬁable. The up-regulation was evaluated in the 120-day
sections and was localized predominantly to endothelial cells
as demonstrated by costaining the lung sections with FITC-
conjugated antibodies to either ICAM-1 or VCAM-1 and
PE-conjugated goat antirabbit antiendothelin antibody.
To quantitatively determine which dilution of antibody
resulted in the least autofluorescence while presenting
maximal positive staining, lung sections were stained with
different dilutions of a rabbit antiendothelin antibody and a
constant PE-conjugated goat antirabbit antibody (Figure 6A),
FITC-conjugated anti–ICAM-1 (Figure 6B), or FITC-
conjugated anti–VCAM-1 (Figure 6C). For all 3 antibodies,
a 1:100 dilution provided the optimal staining for PE or
FITC with the lowest background level of autoﬂuorescence.
The percentage of endothelin-positive cells at 120 days
was similar in control nonirradiated and 20 Gy–irradiated
lungs at each dilution of antibody (Figure 6A). Thus, irradi-
ation did not alter the antiendothelin-positive cell number
per lung section. In contrast, irradiated lung sections
showed a higher percentage of ICAM-1– and VCAM-
1–positive, endothelin-positive cells at 1:50 and 1:100 dilu-
tions of antibodies (Figures 6B and 6C). To conﬁrm that the
irradiation-induced increased ICAM-1 and VCAM-1
expression observed by immunohistochemistry in whole
lung was in anatomically localized endothelial cells, lung
sections were costained with mouse FITC-conjugated anti-
bodies to either ICAM-1 or VCAM-1 and a rabbit antien-
dothelin antibody. The sections were then stained with a
PE-conjugated goat antirabbit antibody, which could detect
the endothelin-positive cells. Increased ICAM-1 (Figure 7A)
and VCAM-1 (Figure 7B) expression was clearly associated
with endothelin-positive cells. The data demonstrate that
the increased expression of ICAM-1 and VCAM-1 in irradi-
ated lung sections at 120 days was in endothelial cells.
To determine whether the histochemically VCAM-1–
positive cells detected in vivo were similar in staining to
in vitro cultured endothelial cells and whether an HA-
Figure 5. Expression of VCAM-1, ICAM-1, P-selectin, and E-selectin
in mouse lungs after irradiation. Control C57BL/6J mice or mice
injected with MnSOD-PL were irradiated to 20 Gy to the pulmonary
cavity and sacriﬁced on days 0, 80, 100, or 120 or at the time of death.
The lungs were frozen in OCT compound, sectioned, and then stained
by immunohistochemistry as described in “Materials and Methods.”
The sections were examined microscopically, and the percentage of
cells expressing the adhesion molecules was determined. There was a
signiﬁcant increase in expression of VCAM-1 and ICAM-1 beginning
at 100 days after irradiation for control irradiated mice compared to
that of nonirradiated mice (P < .0001) or irradiated MnSOD-
PL–treated mice 100 days after irradiation (P < .0001) (1000 cells
scored in 5 slides from each of 5 lobes; 3 mice per point). The increase
in ICAM-1 and VCAM-1 expression was delayed in MnSOD-
PL–treated mice until 120 days after irradiation.
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MnSOD-PL effect was detectable in vitro, pulmonary
endothelial cells were explanted from C57BL/6NHsd
mouse lung to culture using techniques described in “Mate-
rials and Methods.” One half of the cells were HA-
MnSOD-PL–transfected in vitro, whereas the remaining
half of the cells were transfected with LacZ-PL. The trans-
fection procedure had no effect on the viability of the cells,
with more than 95% of cells in each group viable following
transfection. The endothelial cell cultures were irradiated in
vitro to 20 Gy, then 24 hours later were immunohistochem-
ically examined for detectable VCAM-1. Irradiation-
induced VCAM-1 was detected in 29.4% ± 3.8% of the
mock-transfected cells (Figure 8B). HA-MnSOD-PL trans-
duction of endothelial cells in vitro prior to irradiation
demonstrated a significant reduction in VCAM-1–positive
endothelial cells (6.7% ± 1.5%, P = .005) (Figure 8C).
DISCUSSION
Pulmonary complications remain a major dose-limiting
factor in the design of protocols for TBI in patients receiving
BMT [11-14]. The acute effects of TBI with respect to lung
complications have been associated with opportunistic infec-
tions, the interaction of acutely irradiated tissues with donor
bone marrow in graft-versus-host disease, and cytokine
release. TGFβ1-β2, interleukin-1 (IL-1), and tumor necrosis
Figure 6. Dose-response curve for determination of antibody dilutions for costaining lung samples with anti–ICAM-1, anti–VCAM-1, and antien-
dothelin antibodies. Lung sections from nonirradiated mice and from mice irradiated to 20 Gy to the pulmonary cavity were explanted at day 120
and stained with each dilution of antibody to endothelin, ICAM-1, or VCAM-1, as described above. The sections were observed using a ﬂuorescent
microscope, and the percentages of cells positive for endothelin alone (A), ICAM-1 and endothelin (B), or VCAM-1 and endothelin (C) were deter-
mined. The optimal antibody dilution yielding the highest percentage of positive cells for endothelin alone (A), ICAM-1 plus endothelin (B), or
VCAM-1 plus endothelin (C), but yielding the lowest autoﬂuorescence, was a 1:100 dilution for all 3 primary antibodies (the goat antirabbit anti-
body was separately optimized at a 1:100 dilution; see “Materials and Methods”).
VCAM-1 and ICAM-1 in Radiation Lung Fibrosis
183B B & M T
Figure 7. Increased ICAM-1 and VCAM-1 in pulmonary endothelial cells following irradiation. To demonstrate that increased ICAM-1 (A) and
VCAM-1 (B) expression was in the endothelial cells, lung sections of C57BL/6J mice were costained with a rabbit antibody to endothelin and either ham-
ster FITC-conjugated antibody to ICAM-1 (A) or murine FITC-conjugated anti–VCAM-1 (B). The sections were then stained with a PE-conjugated
antirabbit antibody to detect endothelin-positive cells and examined using a ﬂuorescent microscope. In A and B, the top row panel is representative of a
lung section from a mouse that received 20 Gy irradiation 120 days previously. The middle row panel is a section from a mouse that received MnSOD-
PL and 20 Gy irradiation at 120 days previously, whereas the bottom row panel is from a nonirradiated mouse. The ﬁrst column is the ﬂuorescence
obtained from the PE-labeled anti–rabbit-endothelin antibody (red), whereas the second column is the emission from the FITC-labeled anti–ICAM-1
(green) (A) or FITC-labeled anti–VCAM-1 antibody (green) (B). The column on the right is the emission from both ﬂuorochromes with the yellow color
representing cells expressing both endothelin and either ICAM-1 or VCAM-1. Increased expression of ICAM-1 in endothelial cells is shown (A). Mice
injected with MnSOD-PL before 20 Gy irradiation had decreased expression of ICAM-1 compared to the control irradiated mice. B, Increased expres-
sion of VCAM-1 in endothelial cells from control irradiated mice and MnSOD-PL–treated then irradiated mice (original magniﬁcation ×1000).
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factor-α (TNF-α) have been associated with irradiated lung
volumes in TBI [26-30]. The use of fractionation regimens,
transmission of lung blocks, and other shielding techniques
have greatly reduced the acute toxicity of TBI-induced lung
damage. However, reports of late recurrence of tumor asso-
ciated with lung shielding techniques have suggested the
possibility that reduced irradiation doses to the vertebral
bodies and ribs in these shielded areas may compromise total
marrow irradiation doses [12]. Late pulmonary irradiation
damage in long-term survivors of TBI and BMT has pro-
vided a further impetus for research in understanding the
radiation biology of lung damage [11-14].
We have previously demonstrated that 2 peaks of eleva-
tion in levels of TGFβ1-β2 occur in the C57BL/6J female
mouse lung following total lung irradiation [38]. In the
acute irradiation reaction (7-10 days after total lung irradia-
tion), elevation of TGFβ1-β2 is associated with an elevation
of TNF-α and IL-1 as well as other cytokines [38]. In the
late irradiation reaction associated with organizing alveoli-
tis/fibrosis, TNF-α elevation was observed to precede the
late peak of TGFβ1-β2 [38]. This latter peak in elevation of
TGFβ1-β2, but not the earlier increases in TNF-α and IL-1,
was associated with proliferation of ﬁbroblasts in the periph-
eral areas of the lung, as shown by the histopathological
sequelae of organizing alveolitis [43]. In previous studies, we
demonstrated that IT injection of MnSOD-PL reduced
both the early and late peak elevations of cytokines and
decreased the magnitude and severity of organizing alveoli-
tis/ﬁbrosis [38]. In the present studies, we sought to deter-
mine whether there was a MnSOD plasmid dose–dependent
reduction in irradiation damage.
The present studies demonstrate that doses of MnSOD-
PL, at concentrations as low as 250 µg of plasmid DNA, in a
constant volume of 78 µL of plasmid/liposomes, were effec-
tive in reducing the toxicity of 20 Gy total lung irradiation.
In other studies, lower doses of 10 µg and 1 µg were not
detectably effective compared to irradiation alone.
The pathophysiological mechanism of late irradiation
damage has remained a mystery in radiation biology. After
the acute irradiation in the lung, cytokine messenger RNA
and protein levels returned to baseline levels, the histopatho-
logical evidence of alveolar or endothelial cell swelling was
absent, and the pulmonary function tests and other measures
of pulmonary circulation all returned to normal. After an
unexplained latent period, cytokine levels again were elevated,
bronchoalveolar inﬂammatory cell inﬁltrates were detected,
and there was a rapid onset in the mouse model showing a
pattern of organizing alveolitis/ﬁbrosis with proliferation of
fibroblasts and obliteration of normal lung volume [13-
14,38,55]. In the present studies, we sought to determine if
one potential mechanism of this late effect could be explained
by a slowly proliferating cell population requiring 100 days
for expression of irradiation damage [8]. BrdU labeling stud-
ies detected low levels of cellular proliferation throughout the
lung on day 80 and signiﬁcant proliferation in the areas of ini-
tial organizing alveolitis/ﬁbrosis at day 100, extending to day
120, and immediately prior to death. Proliferating cells were
ﬁbroblasts with signiﬁcantly lower, but detectable, numbers
of BAMs. There was no signiﬁcant increase in proliferation
of pulmonary endothelial cells. In contrast, experiments
quantitating intracellular expression of VCAM-1 and ICAM-1,
P-selectin, and E-selectin at the same time points demon-
strated a distinctly different pattern of expression. Pulmonary
cells in the total lung showed a significant increase in
detectable VCAM-1 as early as day 80, with a signiﬁcant, fur-
ther increase up to days 100 and 120. There was also a signiﬁ-
cant increase in ICAM-1 in the periphery of the lung, which
was the principal site of proliferation and detectable BrdU
uptake. No significant increase in E-selectin or P-selectin
expression was seen at any of these time points. Scoring of
immunohistochemically positive cells using speciﬁc costain-
Figure 8. Increased VCAM-1 expression induced in C57BL/6NHsd
mouse pulmonary endothelial cells in vitro by 20 Gy irradiation. Pul-
monary endothelial cells were isolated as described in “Materials and
Methods.” Fifty percent of the cells were transfected with HA-MnSOD
plasmid using lipofectant, whereas the remaining cells were either
untreated or transfected with LacZ plasmid. The cells in each group
were irradiated 24 hours later to 20 Gy and stained 24 hours later with
anti–VCAM-1 antibody. Nonirradiated control endothelial cells (A) are
shown compared to irradiated endothelial cells (B). HA-MnSOD-
PL–transfected cells 24 hours prior to 20 Gy irradiation are shown (C).
VCAM-1 expression (arrow) was significantly increased in irradiated
control cells (B) compared to that in MnSOD-transfected cells (C).
ICAM-1 expression was also increased following irradiation of
endothelial cells, but was decreased in HA-MnSOD-PL–treated cells
(original magniﬁcation ×1000).
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ing with both antiendothelin and anti–VCAM-1 or
anti–ICAM-1 showed a higher positive percentage in
endothelial cells in irradiated lung at 120 days than in whole
lung. Thus, endothelial cells clearly were a large fraction of
the VCAM-1– and ICAM-1–positive cell population detected
at day 120 after 20 Gy irradiation of whole lung.
The evidence from these experiments suggests that up-
regulation of VCAM-1 and ICAM-1 in endothelial cells
occurs approximately 100 days after irradiation and may be
one of the events in late irradiation-induced murine orga-
nizing alveolitis/ﬁbrosis. To determine whether endothelial
cells were detectably transduced by MnSOD-PL following
IT injection (the method shown to be protective in our pre-
vious studies), we used an epitope-tagged HA-MnSOD-PL
for injection. These studies showed that IT as well as IV
injections of HA-MnSOD-PL demonstrated a significant
uptake of the MnSOD construct in endothelial cells.
Because this HA-MnSOD-PL construct was also biochemi-
cally active, the data suggest that the radioprotective effect
of MnSOD-PL administration by IT injection could have
been initiated through events in the endothelial cells.
Ionizing irradiation is known to acutely increase the
expression of VCAM-1, ICAM-1, E-selectin, and P-selectin
in in vitro cultures of endothelial cells, tumor cells, and in
tissue immediately after irradiation [44-45]. In the present
report, we demonstrated that pulmonary endothelial cells
explanted to culture and irradiated in vitro demonstrated
increased acute VCAM-1 activity and that this increase could
be reduced by HA-MnSOD transfection prior to irradiation.
The late increase in VCAM-1– and ICAM-1–positive
endothelial cells in the irradiated lung represents a poten-
tially valuable observation, because the effect followed a
latent period of nearly 100 days after whole lung irradiation.
Whether in vivo administration of HA-MnSOD-PL by
IT injection facilitated enough deposition of the MnSOD
transgene in endothelial cells to be radioprotective and
whether the effect of up-regulation of VCAM-1 at the same
late time points was also inﬂuenced by MnSOD-PL overex-
pression are not known. Furthermore, it is not known whether
those cells with acute up-regulation of VCAM-1 activity after
20 Gy irradiation are the same cells showing increased up-
regulation at 100 to 120 days. Because the BrdU labeling studies
investigated the day 80 and day 100 time points, and because
there were low but detectable levels of increased BrdU at day
80 (although not speciﬁcally localized to endothelial cells), it is
possible that between days 100 and 120 there was signiﬁcant
turnover of endothelial cells, perhaps the same cells that
showed VCAM-1 up-regulation. Further studies in progress,
looking at endothelial cells during these intermediate time
points between days 80 and 120, should resolve this question.
Irradiation of explanted mouse pulmonary endothelial
cells in culture showed that a fraction of these endothelial
cells had increased VCAM-1 expression. Whether these were
cycling cells is not known. Cell cycle synchronization experi-
ments in progress should resolve this question. It is possible
that if VCAM-1 is up-regulated in irradiated cells that go
through a cell cycle, and if further experiments demonstrate
that between the day 80 and day 120 time points there is a
cycling of endothelial cells, the experimental paradigm could
reveal that late endothelial cell cycling mediates events that
are critical to late pulmonary radiation damage.
Other questions include the following: (1) Which cells
in the lung produce the late peak of TGFβ1-β2 detected
after day 100 following 20 Gy irradiation? (2) It is known
that VCAM-1 up-regulation stimulates monocyte adhesion;
therefore, do VCAM-1–up-regulated endothelial cells
actively recruit monocytes to the lung to become BAMs, or
does passive adherence of naturally circulating monocytes
lead to increased monocyte accumulation? It is also not
known whether TGFβ1-β2 is produced by BAMs. Other
studies from our laboratory demonstrate that irradiated
endothelial and bronchoalveolar cells, as well as macro-
phages, can up-regulate TGFβ1-β2. The significant peak
increase in messenger RNA levels for TGFβ1-β2 suggests
that a large number of cells are involved in this up-regulation
[38]. Studies localizing the TGFβ1-β2 increase to specific
cells in the irradiated lung are in progress.
Finally, a question remains regarding the source of prolif-
erating ﬁbroblasts forming the lesions in pulmonary ﬁbrosis.
Pulmonary ﬁbrosis in irradiation damage could be caused by
resident ﬁbroblasts recruited by TGFβ1-β2 to proliferate and
form the ﬁbrotic lesions. The distal site of the ﬁbrotic lesions
in the peripheral lung revealed that accumulation of macro-
phages is also evident, and these cells may induce migration
or proliferation of ﬁbroblasts. Alternatively, ﬁbroblast pro-
genitor cells, perhaps from the bone marrow, could also arrive
after day 80 to the irradiated lung via the circulation. Recent
data from our laboratory support this latter mechanism [56].
The present studies demonstrate that the C57BL/6NHsd
mouse model is a valuable system with which to analyze the
molecular and cellular events involved in late ionizing irradia-
tion damage to the lung. Further studies should elaborate the
cellular and molecular mechanisms of this signiﬁcant compli-
cation of total body irradiation.
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